AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesHealth Care
Dopamine AgentsDopamineReceptors, Dopamine D2Receptors, Dopamine D1Dopamine AgonistsDopamine AntagonistsReceptors, DopamineReceptors, Dopamine D3Dopamine Plasma Membrane Transport ProteinsReceptors, Dopamine D5Dopamine Uptake InhibitorsDopamine beta-HydroxylaseCorpus StriatumQuinpiroleBenzazepinesRacloprideNucleus AccumbensSulpirideHaloperidolApomorphineSalicylamidesCocaineNeostriatumLevodopaAmphetamineDopaminergic NeuronsHomovanillic AcidTyrosine 3-MonooxygenaseDopamine and cAMP-Regulated Phosphoprotein 32MicrodialysisSpiperoneSubstantia NigraVentral Tegmental AreaRats, Sprague-DawleyOxidopamineErgolinesMesencephalonCaudate Nucleusalpha-MethyltyrosineBehavior, AnimalDomperidoneNeuronsDihydroxyphenylalanineNomifensineFlupenthixolMotor ActivityTropanesBromocriptineVesicular Monoamine Transport ProteinsRewardPutamenMethamphetamineBrainBiogenic MonoaminesButaclamolSerotoninDose-Response Relationship, DrugParkinsonian DisordersPrefrontal CortexNorepinephrineCentral Nervous System StimulantsBasal GangliaCatecholaminesReserpineAntiparkinson AgentsStereotyped BehaviorAntipsychotic AgentsMedial Forebrain Bundle1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineParkinson Disease, SecondaryPergolideNerve Tissue ProteinsBrain ChemistryDextroamphetamineCarbidopaLimbic SystemSelf AdministrationClozapineSynaptic TransmissionConditioning, OperantCatechol O-MethyltransferaseHydroxydopaminesSynaptosomesBenztropineDyskinesia, Drug-InducedCatalepsyAromatic-L-Amino-Acid DecarboxylasesAnalysis of VarianceOctopamineCocaine-Related DisordersPyrrolidinesTyramineMethylphenidatePimozideElectrochemical TechniquesTetrahydronaphthalenesBiogenic AminesExtracellular SpaceMPTP PoisoningRats, Wistar
AgonistsReceptorsAgonistTetrabenazineNeurolepticsNorepinephrineSerotoninNeuronsLevodopaAntagonistsNeurotransmitterMedicationNeurotransmissionReceptorStriatalAnaloguesInduceTherapyTherapiesDoseAtypical antipsychoticPresenting symptomBrainIncreasesAnticholinergic agentsDrugsSedationLevelsEffectsSchizophreniaTreatDrugNatural
Agonists13
  • Dopamine agonists suppress tics with few adverse effects and modest but proven efficacy. (medscape.com)
  • Prolactin levels are often adequately suppressed with dopamine-receptor agonists. (medscape.com)
  • Dopamine-receptor agonists make up another pharmacologic option. (medscape.com)
  • 1 In addition, the United Kingdom guidelines recommend that treatment with levodopa should be delayed for as long as possible providing alternative drugs, such as dopamine agonists, can achieve adequate symptom control. (bmj.com)
  • Dopamine agonists exert their antiparkinsonian effects by acting directly on dopamine receptors and mimicking the endogenous neurotransmitter. (bmj.com)
  • 11 There are two subclasses of dopamine agonists: ergoline and non-ergoline agonists. (bmj.com)
  • The ergoline dopamine agonists include bromocriptine, pergolide, lisuride, and cabergoline, whereas ropinirole and pramipexole are non-ergoline agonists. (bmj.com)
  • Apomorphine, one of the first dopamine agonists shown to improve parkinsonian symptoms, is a combined D 1 and D 2 agonist but has to be administered subcutaneously. (bmj.com)
  • Dopamine agonists have proved antiparkinsonian activity. (bmj.com)
  • Dopamine agonists have also been successfully used as monotherapy in de novo patients with the intention of delaying treatment with levodopa and consequently deferring the onset of complications. (bmj.com)
  • Dopamine agonists are not metabolised by oxidative pathways and so do not lead to the cytotoxic free radical formation that may be associated with metabolism of dopamine. (bmj.com)
  • The reason why motor complications are less often encountered with dopamine agonists than with levodopa is not fully understood. (bmj.com)
  • However, patients with LID receive combination therapies that often include dopamine agonists. (lu.se)
Receptors5
  • These agents affect dopamine receptors but also affect serotonin receptors involved with frontal lobe functions. (medscape.com)
  • Pharmacological therapy consists of antidopaminergic therapy with neuroleptics, through the block of dopamine receptors. (eso-stroke.org)
  • Research has proven that romantic attraction activates portions of the brain with high concentrations of receptors for dopamine, Fisher explains. (quantum-self.com)
  • It has affinity for dopamine receptors, especially D2 and for serotinergic receptors: 5HT 2A and 5HT 2C . (europa.eu)
  • Both of these subclasses target dopamine D 2 -type receptors. (bmj.com)
Agonist10
  • Health care professionals should assess patients' need for dopamine agonist (DA) therapy and consider alternative treatment. (medscape.com)
  • After transsphenoidal surgery, these agents are generally a first-line treatment, followed by a dopamine-receptor agonist or GH receptor antagonist. (medscape.com)
  • This is the dopamine-receptor agonist that is most often used to treat GH and prolactin excess. (medscape.com)
  • Cabergoline is a potent dopamine-receptor agonist with a prolonged duration of action. (medscape.com)
  • Parlodel (bromocriptine mesylate) is a dopamine receptor agonist used to treat certain conditions caused by a hormone imbalance in which there is too much prolactin in the blood (hyperprolactinemia), and to treat these disorders when they are caused by brain tumors that can produce prolactin. (rxlist.com)
  • Parlodel® (bromocriptine mesylate) is an ergot derivative with potent dopamine receptor agonist activity. (rxlist.com)
  • Reducing levodopa or dopamine agonist (DA) dosages may partially reduce GD symptoms among patients with co-occurring PD. (springer.com)
  • Bromocriptine (Cycloset) is a dopamine agonist approved for the treatment of type 2 diabetes. (medicinenet.com)
  • Bromocriptine mesylate (Cycloset) is a dopamine agonist. (medicinenet.com)
  • Because an indirect dopaminergic agonist role has been proposed for PCP, we have compared the dopamine (DA)-releasing properties of PCP, amphetamine and certain nonamphetamine stimulants (methylphenidate, nomifensine, amfonelic acid). (utmb.edu)
Tetrabenazine2
  • Tetrabenazine: Medication that decreases dopamine and is used to treat some movement disorders. (oncolink.org)
  • Indeed, tetrabenazine, a dopamine-depleting agent, has become the preferred choice because it does not cause tardive dyskinesia. (eso-stroke.org)
Neuroleptics3
  • They are presynaptic depleting agents that have acute adverse effects similar to neuroleptics but theoretically may avoid the risk of tardive dyskinesia. (medscape.com)
  • No history of metoclopramide, neuroleptics, or other dopamine-depleting agents. (powtoon.com)
  • To the best of our knowledge, preva- definition of what constituted TD and, more lence rate of TD has not been recorded for importantly, the confounding effect of the patients from Arab countries diagnosed type, dosage and duration of the offending with psychosis and being treated with con- agents, and the duration of the illness itself, ventional neuroleptics. (who.int)
Norepinephrine6
  • A norepinephrine-dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine) and dopamine in the body and/or brain. (wikipedia.org)
  • A closely related type of drug is a norepinephrine-dopamine reuptake inhibitor (NDRI). (wikipedia.org)
  • Theorized that action may be related to mediation through the reversible inhibition of vesicular monoamine transporter 2 (VMAT2), a transporter that decreases uptake of monoamines (eg, dopamine, serotonin, norepinephrine, histamine) into synaptic vesicles and depletes monoamine stores from nerve terminals. (medscape.com)
  • Because your brain is experiencing a biochemical rush of dopamine, norepinephrine and phenylethylamine close chemical cousins to amphetamines. (quantum-self.com)
  • Other scientific studies have linked high levels of dopamine and a related agent, norepinephrine to heightened attention and short-term memory, hyperactivity, sleeplessness and goal-oriented behavior. (quantum-self.com)
  • 17. Cathinone, like amphetamine, is a potent agent that causes norepinephrine and dopamine to be launched in the 30 physique impotence yoga poses [url=https://www.digrajshahirange.gov.bd/order/Kamagra-Oral-Jelly/]100 mg kamagra oral jelly overnight delivery[/url]. (ehd.org)
Serotonin5
  • Risperidone is a mixed dopamine-serotonin antagonist that may produce less sedation than other antipsychotics. (medscape.com)
  • This agent depletes neurotransmitter stores of dopamine, serotonin, and noradrenaline within nerve cells in the brain, thereby altering the transmission of electric signals from the brain that control movement by reversibly inhibiting vesicular monoamine transporter 2 (VMAT2). (medscape.com)
  • CBD is a natural anti-inflammatory agent, and it reduces pain by increasing serotonin and dopamine levels in the body. (hubickart.com)
  • the dopamine hypersensitivity hypothesis and the serotonin-dopamine antagonist hypothesis. (who.int)
  • The neuroleptic-induced TD with those who did serotonin-dopamine antagonist hypothesis not develop it under comparatively similar maintains that drugs which have a high conditions. (who.int)
Neurons5
Levodopa3
  • Levodopa is in a class of medications called central nervous system agents. (medlineplus.gov)
  • Levodopa belongs to a class of drugs known as central nervous system agents. (naturalpedia.com)
  • BACKGROUND: Current models of levodopa (L-dopa)-induced dyskinesia (LID) are obtained by treating dopamine-depleted animals with L-dopa. (lu.se)
Antagonists4
  • The combination of dopamine antagonists with stimulants is used sometimes, yet it makes little enough sense pharmacologically that other options should be explored thoroughly. (medscape.com)
  • therefore, an adequate trial with this medication is reasonable before using dopamine antagonists. (medscape.com)
  • Concomitant treatment with dopamine antagonists such as metoclopramide may result in diminution of the effects of both drugs on the gastrointestinal tract. (janusinfo.se)
  • Somatostatin and dopamine analogues and GH receptor antagonists are the mainstays of medical treatment for GH excess and are generally used when primary surgery fails to induce complete remission. (medscape.com)
Neurotransmitter3
  • Dopaminergic Agents: Medication that increases the neurotransmitter dopamine. (oncolink.org)
  • Dopamine is both a hormone (catecholamine) and a chemical messenger (neurotransmitter), produced in the brain and adrenal gland, and has multiple functions. (medicinenet.com)
  • Dopamine is most known for its central nervous system role as a neurotransmitter in the regulation of movement, learning, memory, cognition, and emotion. (medicinenet.com)
Medication1
  • Dopamine is a medication administered intravenously to correct imbalances in the blood circulation dynamics (hemodynamics) due to shock , including low blood pressure ( hypotension ), low cardiac output, and poor perfusion of vital organs. (medicinenet.com)
Neurotransmission3
  • Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. (cdc.gov)
  • Here we characterized the effects of the broadly-used insecticide chlorpyrifos on dopamine and glutamatergic neurotransmission effectors in corticostriatal motor/reward circuitry. (cdc.gov)
  • The effi- risk of infection - DBS requires battery changes cacy of dopaminergic drug treatment provides a com- with a clear physical and somewhat unsightly pelling rationale for the use of dopamine cell thera- reminder of an intervention, as is evident by pies to restore striatal dopamine neurotransmission. (lu.se)
Receptor1
  • Laboratory results included the following: leukocyte count 19,830/mm³ with 97% polynuclear neutrophils, platelets 90,000/mm³, creatinine 2.1 mg/dL, bicarbonate 13 mEq/L, cyclic AMP receptor protein 43.7 ng/mL, creatine kinase 514 U/L. Cultures of blood, stool, and urine samples were negative for microbial agents. (cdc.gov)
Striatal1
  • Vickroy, TW & Johnson, KM 1982, ' Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices ', Journal of Pharmacology and Experimental Therapeutics , vol. 233, no. 3, pp. 669-674. (utmb.edu)
Analogues1
  • They have modest effects if used as single agents and are usually added to somatostatin analogues if complete remission has not been achieved. (medscape.com)
Induce1
  • These are the agents that should be exclusively classified as hypnotics and utilized to induce sleep when medications are required to treat the complaint of insomnia. (springer.com)
Therapy1
  • The treatment included aggressive intravenous fluid resuscitation, administration of dopamine, and antimicrobial agent therapy with teicoplamin and clindamycin. (cdc.gov)
Therapies1
  • This brings as oral dopamine therapies with the advantage that with it continued infective risks for the patients the cells can be targeted to the site where dopamine with DBS which is not so for patients with trans- is most needed, namely the striatum. (lu.se)
Dose2
  • Low dose of dopamine increases blood flow to the kidneys and urine output. (medicinenet.com)
  • It usually appears while consistently reported risk factors which the patient is still on the offending agent or were found to make some patients more appears for the first time when the drug is vulnerable to developing TD if treated with discontinued or its dose is reduced. (who.int)
Atypical antipsychotic1
  • Sertindole is an atypical antipsychotic agent. (europa.eu)
Presenting symptom1
  • If severe tics are the presenting symptom, a newer antipsychotic agent may be the best initial treatment. (medscape.com)
Brain6
Increases1
  • In the treatment of hemodynamic imbalance, dopamine stimulates cardiac muscle contraction and increases the heart rate, which results in improved cardiac output. (medicinenet.com)
Anticholinergic agents2
  • Elevation of intraocular pressure may be produced by the administration of anticholinergic agents such as Buscopan in patients with undiagnosed and therefore untreated narrow angle glaucoma. (janusinfo.se)
  • and the indiscriminate use clude heterogeneity of the populations un- of anticholinergic agents [7,8,12,17-22]. (who.int)
Drugs1
  • Insomnia inducing drugs include caffeine, nicotine, weight loss preparations, and activating agents of both prescription and abuse. (springer.com)
Sedation3
  • In this brief overview, medications used to treat insomnia such as hypnotics, sedatives, medications inducing sedation as a side effect, medications directed at the sleep-associated circadian neuroendocrine system, and agents utilized in treating insomnia-inducing sleep diagnoses such as restless leg syndrome are discussed. (springer.com)
  • Other pharmacological agents producing sedation (sedatives and agents used off-label for sedative side-effects) should be used cautiously for the treatment of insomnia due to the increased risk of next day sleepiness as well as for known toxicities and adverse side effects. (springer.com)
  • Medications for treating insomnia are classified as hypnotics, sedatives, medications inducing sedation as a side effect, medications directed at the sleep-associated circadian neuroendocrine system, and agents utilized in treating insomnia-inducing sleep diagnoses such as restless leg syndrome (RLS) (Curry et al. (springer.com)
Levels1
  • However, circulating GH and insulinlike growth factor ̶ I (IGF-I) levels rarely normalize with these agents. (medscape.com)
Effects2
Schizophrenia3
  • In a head-to-head study, this agent caused less weight gain than olanzapine in schizophrenia. (medscape.com)
  • In spite of extensive research on the biological and behavioral correlates of dopamine (DA) function, little is known about the mechanisms by which DA may produce the cognitive deficits observed in schizophrenia. (princeton.edu)
  • Cohen, JD & Servan-schreiber, D 1993, ' A theory of dopamine function and its role in cognitive deficits in schizophrenia ', Schizophrenia Bulletin , vol. 19, no. 1, pp. 85-104. (princeton.edu)
Treat1
  • The possibility of MRSA must be considered when initiating antimicrobial agents to treat TSS. (cdc.gov)
Drug1
  • Carboxylic acid commonly used as antiepileptic drug, mood stabilizer in mania, and prophylactic agent for migraine. (medscape.com)
Natural1